Summary - On January 31st at the Biomanufacturing Summit there was a manufacturing technology workshop titled “Analysis of Upstream Cost of Goods” presented by John Bonham-Carter, Vice President, Sales and Business Development for Refine Technology. This was a sponsored presentation where Bonham-Carter presented arguments that perfusion bioreactor systems will be used in the future for biomanufacturing of therapeutic proteins and antibodies and will significantly lower the cost of goods. Read More

November 30, 2011 – The National Institutes of Health (NIH) awarded InVitria a $725,000 Phase II, Small Business Innovation Research (SBIR) Grant to broaden the applications for InVitria’s recombinant human serum albumin product Cellastim®... read more